CORC  > 暨南大学
miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis
Song, Changshan[1]; Lu, Pingfang[2]; Sun, Guoqiang[2]; Yang, Lin[3]; Wang, Zhigang[2]; Wang, Zheng[3]
2017
卷号482期号:[db:dc_citation_issue]页码:22
DOI[db:dc_identifier_doi]
URL标识查看原文
WOS记录号[DB:DC_IDENTIFIER_WOSID]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3352234
专题暨南大学
作者单位1.[1]Jinan Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510630, Guangdong, Peoples R China
2.[2]Guangdong Med Univ, Affiliated Hosp, Dept Thorac Surg, Zhanjiang 524023, Guangdong, Peoples R China
3.[3]Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Thorac Surg, Shenzhen 518020, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Song, Changshan[1],Lu, Pingfang[2],Sun, Guoqiang[2],et al. miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis[J],2017,482([db:dc_citation_issue]):22.
APA Song, Changshan[1],Lu, Pingfang[2],Sun, Guoqiang[2],Yang, Lin[3],Wang, Zhigang[2],&Wang, Zheng[3].(2017).miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.,482([db:dc_citation_issue]),22.
MLA Song, Changshan[1],et al."miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis".482.[db:dc_citation_issue](2017):22.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace